Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 06 2020
23 06 2020
Historique:
received:
25
02
2020
accepted:
28
05
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
15
12
2020
Statut:
epublish
Résumé
This study was to investigate the correlation of vagal activity with coronary artery lesion (CAL) in Kawasaki disease (KD) children, and assess the predictive value of heart rate deceleration capacity (DC) for CAL in acute phase of KD.50 KD children with CAL, 130 KD children without CAL, 30 children with acute upper respiratory infection and 100 healthy children were recruited and indicators reflecting vagal activity including DC were measstuogram. KD children with CAL showed decreased vagal activity with significantly lower values of DC. DC was negatively correlated with levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) in KD children. DC was a usable cardiac electrophysiological index to predict CAL in children with KD, with an area under the receiver operating characteristic curve (AUC) of 0.741. The cut-off value of DC for predicting CAL in KD children was 4.37 ms. DC was an independent predictor of CAL in children with KD, evaluated by multiple logistic regression analysis, KD children with DC ≤ 4.37 ms had an increased risk of CAL, with odds ratios (OR) of 5.94. Our study illustrates DC could be used to predict CAL in acute phase of KD.
Identifiants
pubmed: 32576944
doi: 10.1038/s41598-020-67121-3
pii: 10.1038/s41598-020-67121-3
pmc: PMC7311450
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10211Références
Wood, L. E. & Tulloh, R. M. R. Kawasaki disease in children. Heart 95, 787–92 (2009).
doi: 10.1136/hrt.2008.143669
Kuo, H. C. Preventing coronary artery lesions in kawasaki disease. Biomed J. 40, 141–46 (2017).
doi: 10.1016/j.bj.2017.04.002
Duan, C., Du, Z. D., Wang, Y. & Jia, L. Q. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to kawasaki disease. World J Pediatr 10, 232–237 (2014).
doi: 10.1007/s12519-014-0498-5
Holve, T. J. et al. Long-term cardiovascular outcomes in survivors of kawasaki disease. Pediatrics 133, e305–11 (2014).
doi: 10.1542/peds.2013-1638
Min, K. K., Min, S. S. & Gi, B. K. F. Factors predicting resistance to intravenous immunoglobulin treatment and coronary artery lesion in patients with kawasaki disease: analysis of the korean nationwide multicenter survey from 2012 to 2014. Korean Circ J 48, 71–9 (2018).
doi: 10.4070/kcj.2017.0200
Jun, H. et al. Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in kawasaki disease. Korean J Pediatr 59, 298–302 (2016).
doi: 10.3345/kjp.2016.59.7.298
Kobayashi, T. et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with kawasaki disease. Circulation 113, 2606–12 (2006).
doi: 10.1161/CIRCULATIONAHA.105.592865
Kaneko, K. et al. Prediction of the risk of coronary arterial lesions in kawasaki disease by brain natriuretic peptide. Pediatr Cardiol 32, 1106–9 (2011).
doi: 10.1007/s00246-011-9986-8
Ewing, D. J., Borsey, D. Q., Bellavere, F. & Clarke, B. F. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 21, 18–24 (1981).
doi: 10.1007/BF03216217
Paiva, V. C. et al. Comparison of assessment methods of cardiac vagal modulation. Arq Bras Cardiol 97, 493–501 (2011).
doi: 10.1590/S0066-782X2011005000109
Bigger, J. T., Fleiss, J. L., Rolnitzky, L. M. & Steinman, R. C. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 21, 729–36 (1993).
doi: 10.1016/0735-1097(93)90106-B
Yıldız, B. S. et al. Evaluation of heart rate variability in patients with coronary artery ectasia and coronary artery disease. Turk Kardiyol Dern Ars 44, 306–314 (2016).
pubmed: 27372615
Wennerblom, B., Lurje, L., Tygesen, H., Vahisalo, R. & Hjalmarson, A. Patients with uncomplicated coronary artery disease have reduced heart rate variability mainly affecting vagal tone. Heart 83, 290–4 (2000).
doi: 10.1136/heart.83.3.290
Li, H. R. et al. Additive value of heart rate variability in predicting obstructive coronary artery disease beyond framingham risk. Circ J 80, 494–501 (2016).
doi: 10.1253/circj.CJ-15-0588
Hamm, W. et al. Deceleration capacity of heart rate after acute altitude exposure. High Alt Med Biol 19, 299–302 (2018).
doi: 10.1089/ham.2018.0041
Bauer, A. et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367, 1674–81 (2006).
doi: 10.1016/S0140-6736(06)68735-7
Pan, Q. et al. The degree of heart rate asymmetry is crucial for the validity of the deceleration and acceleration capacity indices of heart rate: a model-based study. Comput Biol Med 76, 39–49 (2016).
doi: 10.1016/j.compbiomed.2016.06.017
Guzik, P. et al. Heart rate deceleration runs for postinfarction risk prediction. J Electrocardiol 45, 70–6 (2012).
doi: 10.1016/j.jelectrocard.2011.08.006
McCrindle, B. W. et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation 135, e927–99 (2017).
doi: 10.1161/CIR.0000000000000484
Burns, J. C. & Matsubara, T. New insights into cardiovascular disease in patients with kawasaki disease. Curr Opin Pediatr 30, 623–27 (2018).
doi: 10.1097/MOP.0000000000000673
McCrindle, B. W. et al. Coronary artery involvement in children with kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116, 174–9 (2007).
doi: 10.1161/CIRCULATIONAHA.107.690875
Kikuchi, Y., Sato, Y., Ichihashi, K., Shiraishi, H. & Momoi, M. Y. Autonomic function in kawasaki disease with myocardial infarction: usefulness of monitoring heart rate variability. Pediatr Int 45, 407–9 (2003).
doi: 10.1046/j.1442-200X.2003.01742.x
Kinugasa, H. & Hirayanagi, K. Effects of skin surface cooling and heating on autonomic nervous activity and baroreflex sensitivity in humans. Exp Physiol 84, 369–77 (1999).
doi: 10.1111/j.1469-445X.1999.01839.x
Massaro, A. N. et al. Effect of temperature on heart rate variability in neonatal ICU patients with hypoxic-ischemic encephalopathy. Pediatr Crit Care Med 18, 349–54 (2017).
doi: 10.1097/PCC.0000000000001094
Agarwal, S. & Agrawal, D. K. Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol 13, 247–258 (2017).
doi: 10.1080/1744666X.2017.1232165
Heck, P. B., Müller, J., Weber, R. & Hager, A. Value of N-terminal pro-brain natriuretic peptide levels in different types of fontan circulation. Eur J Heart Fail 15, 644–49 (2013).
doi: 10.1093/eurjhf/hft063
Hwang, J., Seo, Y., Jo, Y., Son, J. & Choi, J. Aptamer-conjugated live human immune cell based biosensors for the accurate detection of c-reactive protein. Sci Rep 6, 34778 (2016).
doi: 10.1038/srep34778
Zhao, M. et al. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion. Basic Res Cardiol 108, 345 (2013).
doi: 10.1007/s00395-013-0345-1
Moser, M. et al. Investigation of a micro-test for circulatory autonomic nervous aystem responses. Front Physiol 21, 448 (2017).
doi: 10.3389/fphys.2017.00448
Lorgis, L. et al. High N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction. PLoS ONE 7, e44677 (2012).
doi: 10.1371/journal.pone.0044677
Rauchenzauner, M. et al. N-terminal pro-brain natriuretic peptide (NT-proBNP) release in children with vagus nerve stimulation. A prospective case series. J Neurol 255, 980–5 (2008).
doi: 10.1007/s00415-008-0804-z
Yu, H. et al. Chronic vagus nerve stimulation improves left ventricular function in a canine model of chronic mitral regurgitation. J Transl Med 12, 302 (2014).
doi: 10.1186/s12967-014-0302-2
Sloan, R. P. et al. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med Camb Mass 13, 178–84 (2007).
pubmed: 17592552
Rizas, K. D. et al. Bedside autonomic risk stratification after myocardial infarction by means of short-term deceleration capacity of heart rate. Europace 20, f129–36 (2018).
doi: 10.1093/europace/eux167
Hu, W. et al. Deceleration and acceleration capacities of heart rate associated with heart failure with high discriminating performance. Sci Rep 6, 23617 (2016).
doi: 10.1038/srep23617
Yoshimura, K. et al. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in kawasaki disease. J Pediatr 162, 1205–9 (2013).
doi: 10.1016/j.jpeds.2012.11.026